SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)*
Facet Biotech Corporation
-----------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 par value
-----------------------------------------------------
(Title of Class of Securities)
30303Q103
-----------------------------------------------------
(CUSIP Number)
September 30, 2009
-----------------------------------------------------
(Date of Event Which requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[X] Rule 13d-1(b)
[_] Rule 13d-(c)
[_] Rule 13d-1(d)
----------
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 8 Pages
CUSIP No. 30303Q103 Schedule 13G Page 2 of 8 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Iridian Asset Management LLC
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES N/A
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY N/A
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING N/A
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH N/A
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
N/A
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
N/A
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IA
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 30303Q103 Schedule 13G Page 3 of 8 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
David L. Cohen
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES N/A
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY N/A
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING N/A
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH N/A
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
N/A
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
N/A
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 30303Q103 Schedule 13G Page 4 of 8 Pages
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Harold J. Levy
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [X]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES N/A
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY N/A
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING N/A
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH N/A
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
N/A
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
N/A
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 30303Q103 SCHEDULE 13G Page 5 of 8 Pages
This Amendment amends in its entirety the Schedule 13G previously filed for the
month ended December 31, 2008.
________________________________________________________________________________
Item 1(a). Name of Issuer:
Facet Biotech Corporation
________________________________________________________________________________
Item 1(b). Address of Issuer's Principal Executive Offices:
1500 Seaport Blvd.
Redwood City, CA 94063
________________________________________________________________________________
Item 2.
(a) Name of Person Filing.
This Statement is being filed by and on behalf of Iridian Asset Management LLC
("Iridian"), David L. Cohen ("Cohen") and Harold J. Levy ("Levy") (collectively,
the "Reporting Persons").
Effective June 30, 2009, Cohen and Levy indirectly acquired ownership and
control of 100% of the equity interests of Iridian from BIAM (US) Inc., an
indirect wholly owned subsidiary of The Governor and Company of the Bank of
Ireland. Thus, on that date, Cohen and Levy may be deemed to have acquired
beneficial ownership of all shares of Common Stock beneficially owned by
Iridian.
Iridian is majority owned by Arovid Associates LLC, a Delaware limited liability
company owned and controlled by the following: 12.5% by Cohen, 12.5% by Levy,
37.5% by LLMD LLC, a Delaware limited liability company, and 37.5% by ALHERO
LLC, a Delaware limited liability company. LLMD LLC is owned 1% by Cohen, and
99% by a family trust controlled by Cohen. ALHERO LLC is owned 1% by Levy and
99% by a family trust controlled by Levy.
(b) Address of Principal Business Office:
The principal business address of the Reporting Persons is 276 Post Road West,
Westport, CT 06880-4704.
(c) Citizenship or Place of Organization:
Iridian is a Delaware limited liability company. Cohen and Levy are US
citizens.
d) Title of Class of Securities:
This Statement relates to the shares of common stock, $0.01 par value, of
Facet Biotech Corporation.
(e) CUSIP Number: The CUSIP number is 30303Q103.
CUSIP No. 30303Q103 SCHEDULE 13G Page 6 of 8 Pages
_______________________________________________________________________________
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or
(c), Check Whether the Person Filing is a:
(a) [_] Broker or dealer registered under Section 15 of the Exchange Act.
(b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange
Act.
(d) [_] Investment company registered under Section 8 of the Investment
Company Act.
(e) [X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) [_] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) [_] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
(h) [_] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) [_] A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act;
(j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1(c), check this box. [_]
_______________________________________________________________________________
Item 4. Ownership.
Not applicable.
CUSIP No. 30303Q103 SCHEDULE 13G Page 7 of 8 Pages
________________________________________________________________________________
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following: X
________________________________________________________________________________
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
Not applicable.
________________________________________________________________________________
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
Not applicable.
________________________________________________________________________________
Item 8. Identification and Classification of Members of the Group.
Not applicable
________________________________________________________________________________
Item 9. Notice of Dissolution of Group.
Not applicable.
________________________________________________________________________________
Item 10. Certifications.
By signing below the undersigned certifies that, to the best of its or his
knowledge and belief, the securities referred to above were acquired and are
held in the ordinary course of business and were not acquired and are not held
for the purpose of and do not have the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having such purpose or
effect.
CUSIP No. 30303Q103 SCHEDULE 13-G Page 8 of 8 Pages
SIGNATURE.
After reasonable inquiry and to the best of its or his knowledge and belief, we
certify that the information set forth in this statement is true, complete and
correct.
Date: October 6, 2009
IRIDIAN ASSET MANAGEMENT LLC
By: /s/ Jeffrey M. Elliott
----------------------------------
Jeffrey M. Elliott
Executive Vice President
By: /s/ David L. Cohen
----------------------------------
David L. Cohen
By: /s/ Harold J. Levy
----------------------------------
Harold J. Levy